Trial Condition(s):

Atopic dermatitis, Eczema

Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD)

Bayer Identifier:

15616

ClinicalTrials.gov Identifier:

NCT01359787

EudraCT Number:

2010-024279-14

Study Completed

Trial Purpose

The purpose of this study is to evaluate the efficacy and safety of three concentrations of a development drug compared to ointment base (vehicle) in subjects with Atopic Dermatitis (AD).

Inclusion Criteria
- Signed written informed consent
- Diagnosis of atopic dermatitis according to Hanifin and Rajka Criteria
- Willingness of subject to follow all study procedures
- Willingness to avoid excessive exposure of diseased areas to natural or artificial sunlight
Exclusion Criteria
- Pregnancy and breast-feeding
- Clinically relevant disease, which could interfere with the study conduct or the evaluation and interpretation of the study results
- Clinically manifested immunosuppressive disorder or known history of malignant disease
- History of relevant drug and/or food allergies

Trial Summary

Enrollment Goal
197
Trial Dates
black-arrow
Phase
2
Could I receive a placebo?
No
Products
Mapracorat (BAY86-5319)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Intendis GmbH

Berlin, Germany, 10589

Status
Completed
 

Trial Design